NAD+ supplements: separating real science from TikTok hype

What's this video probably claiming?

Based on the caption and hashtag set, this creator is likely walking viewers through NAD+ as a coenzyme involved in cellular energy metabolism, pitching it as an anti-aging compound tied to mitochondrial function. The "how to reconstitute NAD+" framing is telling: this signals the video probably discusses injectable NAD+, not just oral supplements. That's a meaningful distinction most social media content glosses over entirely. The creator also flags gimmicks to watch for, which is a relatively responsible framing for this space. Expect claims about NAD+ declining with age, precursors like NMN and NR being effective oral alternatives, and injectable NAD+ producing faster or superior results. The peptide-adjacent community has latched onto NAD+ hard over the past two years, and this video appears to be targeting that audience specifically.

What does the science actually show?

NAD+ does decline with age. That part is real. Verdin (2015, Science) documented age-related NAD+ depletion in multiple tissues and linked it to metabolic dysfunction. The question is whether supplementing it does anything meaningful in otherwise healthy adults. Yoshino et al. (2021, Science) showed that NMN supplementation at 250mg daily for 10 weeks improved muscle insulin sensitivity in postmenopausal women with prediabetes. That's a specific population, not a universal anti-aging result. Trammell et al. (2016, Nature Communications) confirmed NR raises blood NAD+ levels in humans at doses around 1,000mg daily, but blood NAD+ levels are a surrogate marker, not a clinical outcome. Intravenous NAD+ has been studied primarily in addiction contexts, not longevity. The honest read: precursor supplementation raises NAD+ in blood, and that may matter in metabolic disease. Whether it extends healthy lifespan or reverses aging in humans remains genuinely unproven.

Where does the social media noise diverge from clinical reality?

Several divergences are predictable here. First, conflating mouse data with human outcomes. Sinclair et al. (2013, Cell) showed NMN reversed vascular aging in mice. Mice are not humans, and that study is cited constantly in longevity content without the caveat that human translation has been slow and modest. Second, the reconstitution framing suggests the video may imply injectable NAD+ is superior to oral precursors. There is no published RCT comparing IV NAD+ to oral NMN or NR for longevity outcomes in healthy adults. Third, the anti-aging hashtag is doing a lot of work. NAD+ has not been shown to extend lifespan in humans in any clinical trial. Fourth, oral NR and NMN are often presented as interchangeable, but their metabolic fates differ somewhat according to Tramell et al. (2016). And fifth, high-dose IV NAD+ sessions marketed at wellness clinics are priced at $300 to $1,000 per infusion with zero RCT support for the outcomes being sold.

What should you actually know?

NAD+ precursors are reasonably safe at studied doses and do raise NAD+ levels in blood. If you have metabolic dysfunction, prediabetes, or are in a population like the one studied by Yoshino et al. (2021), there may be a real signal worth discussing with a clinician. For healthy adults chasing longevity, the evidence is thin and the marketing is thick. Injectable NAD+ requires sterile reconstitution technique, appropriate sourcing from a licensed compounding pharmacy, and medical supervision. It is not a casual DIY project. The flushing and nausea side effects of IV NAD+ are significant and commonly understated in social content. Oral NMN and NR have better tolerability profiles at studied doses. Any content claiming NAD+ cures disease, reverses aging definitively, or should be self-administered without medical oversight is overstating the science considerably. The biology is genuinely interesting. The product ecosystem around it is largely running ahead of the data.